SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-061058
Filing Date
2012-11-13
Accepted
2012-11-13 06:35:25
Documents
3
Period of Report
2012-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v328179_8k.htm 8-K 23423
2 EXHIBIT 4.1 v328179_ex4-1.htm EX-4.1 50784
3 EXHIBIT 10.1 v328179_ex10-1.htm EX-10.1 38204
  Complete submission text file 0001144204-12-061058.txt   114039
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 121195468
SIC: 2834 Pharmaceutical Preparations